Federico Hinestrosa, MD

Associate Medical Director
Orlando Immunology Center, University of Central Florida College of Medicine

Poster(s):

• (1603) Efficacy, safety and tolerability of switching to dolutegravir/lamivudine in virologically suppressed adults living with HIV on bictegravir/emtricitabine/tenofovir alafenamide -the DYAD study
  Friday, October 13, 2023

  12:15 PM – 1:30 PM US ET